| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/26/2006 | CA2587361A1 Peptidomimetic polymers for antifouling surfaces |
| 05/26/2006 | CA2586615A1 Pro87299 (btla), and variants thereof, for treating immune related disorders |
| 05/26/2006 | CA2586395A1 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 05/26/2006 | CA2586365A1 Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
| 05/26/2006 | CA2586228A1 Histone deacetylase inhibitors and methods of use |
| 05/26/2006 | CA2586213A1 Formulations, methods of production and uses of fgf-20 |
| 05/26/2006 | CA2585549A1 Novel type leptin receptor antagonist |
| 05/25/2006 | US20060112441 CYT28 serpentine receptor disruptions, compositions and methods relating thereto |
| 05/25/2006 | US20060111585 Title of the invention n-cyclohexylaminocarbonyl benzensulfonmide derivatives |
| 05/25/2006 | US20060111562 Human SDF-5 protein and compositions |
| 05/25/2006 | US20060111561 Novel proteins and nucleic acids encoded thereby |
| 05/25/2006 | US20060111559 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 05/25/2006 | US20060111553 Novel thrombin inhibitors, the preparation and use thereof |
| 05/25/2006 | US20060111552 Metal binding precursors for the synthesis of peptide-metal conjugates |
| 05/25/2006 | US20060111551 Peptide having HTLV-1-specific CTL-inducing activity |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111316 Treatment of inflammatory, non-infectious, autoimmune, vasculitic, degenerative vascular, host-v-graft diseases, Alzheimers disease, and amyloidosis using mammalian, dsDNA vaccination |
| 05/25/2006 | US20060111313 modulating calvarial osteoblast differentiation and mineralization in human by altering expression or activity of Nell-1 in human, wherein increased expression or activity of Nell-1 increases osteoblast differentiation or mineralization and decreased expression decreases osteoblast differentiation |
| 05/25/2006 | US20060111312 Antigene locks and therapeutic uses thereof |
| 05/25/2006 | US20060111304 For therapy of pancreatitus, bilioecholic, gastroesophical relux (GERD), irritable bowel syndrome (IBS), non ulcerous dyspepsia |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/25/2006 | US20060111302 Compositions and methods to reduce mutagenesis |
| 05/25/2006 | US20060111301 Methods for preventing and treating alzheimer's disease |
| 05/25/2006 | US20060111300 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
| 05/25/2006 | US20060111299 Compositions and methods for treating atherosclerosis |
| 05/25/2006 | US20060111298 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 05/25/2006 | US20060111297 Blood factor domains |
| 05/25/2006 | US20060111296 Plasmin-inhibitory therapies |
| 05/25/2006 | US20060111295 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in the treatment of arthritis, inflammation and immune disorders |
| 05/25/2006 | US20060111294 Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells |
| 05/25/2006 | US20060111293 Antagonists for human prolactin |
| 05/25/2006 | US20060111292 Using gene-regulatory peptide |
| 05/25/2006 | US20060111291 UV device for treating osteolysis |
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060111289 Compositions and methods of using Alpha-fetoprotein growth inhibitory peptides |
| 05/25/2006 | US20060111288 Peripheral benzodiazepine receptor independent superoxide generation |
| 05/25/2006 | US20060111287 Acetylated protein |
| 05/25/2006 | US20060111286 Method of modulating endothelial cell activity |
| 05/25/2006 | US20060111285 Use of granme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 05/25/2006 | US20060111284 Method for treating cancer |
| 05/25/2006 | US20060111283 Prevention therapy and prognosis/monitoring in sepsis and septic shock |
| 05/25/2006 | US20060111282 for treatment of blood coaggulation disorders; trauma |
| 05/25/2006 | US20060111281 Melanocortin receptor-specific |
| 05/25/2006 | US20060111280 Novel substance fki-1033 and process for producing the same |
| 05/25/2006 | US20060111279 Glycopegylated erythropoietin |
| 05/25/2006 | US20060111278 TFF peptides |
| 05/25/2006 | US20060111277 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water |
| 05/25/2006 | US20060111276 Enhanced oral bioavailability and increased uptake of the compound by gastrointestinal tract membrane transporter |
| 05/25/2006 | US20060111275 Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols |
| 05/25/2006 | US20060111274 Methods and compositions for enhancing transport across biological membranes |
| 05/25/2006 | US20060111273 Water soluble paclitaxel derivatives |
| 05/25/2006 | US20060111272 such as psoriasis and inflammatory bowel disease, in a human or other host animals; 2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid |
| 05/25/2006 | US20060111271 Active and passive immunization against pharmacologically active hapten molecules using a synthetic carrier compound composed of similar elements |
| 05/25/2006 | US20060110802 DNA encoding novel 4-1BB ligand (4-1BB-L) polypeptides which are members of the tumor necrosis factor (TNF) receptor super-family; expression vectors and antibodies; use to stimulate proliferation of activated T-cells for immunotherapy |
| 05/25/2006 | US20060110801 Receptor for b. anthracis toxin |
| 05/25/2006 | US20060110800 Testis-specific receptor |
| 05/25/2006 | US20060110799 Mitogen-activated protein kinase kinase MEK6 and methods of use thereof |
| 05/25/2006 | US20060110790 Expression system for large functional proteins |
| 05/25/2006 | US20060110779 Method for detecting a lectin-like substance |
| 05/25/2006 | US20060110772 Human and murine cytokine polypeptides |
| 05/25/2006 | US20060110770 Administering polypeptide of given sequence, which hydrolyzes DNA in sputum of cystic fibrosis patients |
| 05/25/2006 | US20060110769 Regulation of novel human prolyl 4-hydroxylases |
| 05/25/2006 | US20060110731 Cancer-linked gene as target for chemotherapy |
| 05/25/2006 | US20060110492 Preparation and food product comprising an active phytase |
| 05/25/2006 | US20060110460 dissolving active principle in water; emulsifying resulting solution of active principle with d,l-lactide-co-glycolide matrix copolymer, emulsifying first emulsion in external aqueous phase containing surfactant, viscosity-enhancing agent, osmotic agent, extraction-evaporation to form microspheres |
| 05/25/2006 | US20060110441 Lyophilized liposome formulations and method |
| 05/25/2006 | US20060110437 Synthesis and self-assembly of abc triblock bola peptide |
| 05/25/2006 | US20060110425 Leech extracts for stents |
| 05/25/2006 | US20060110423 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent |
| 05/25/2006 | US20060110422 Conversion of calcite powders into macro- and microporous calcium phosphate scaffolds for medical applications |
| 05/25/2006 | US20060110410 Recombinant toxin fragments |
| 05/25/2006 | US20060110409 Targeted agents for nerve regeneration |
| 05/25/2006 | US20060110408 Immunological combination compositions and methods |
| 05/25/2006 | US20060110400 Immunogenic conjugates |
| 05/25/2006 | US20060110396 Use of ligands of the antigen CDw52 for the treatment of diseases that are related to degenerated macrophages |
| 05/25/2006 | US20060110394 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
| 05/25/2006 | US20060110393 Novel proteins and use thereof |
| 05/25/2006 | US20060110391 Compositions and methods for the treatment of body weight disorders, including obesity |
| 05/25/2006 | US20060110390 Inhibition of Ku as a treatment for cardiovascular diseases |
| 05/25/2006 | US20060110384 Novel proteins and use thereof |
| 05/25/2006 | US20060110383 carcinoma; parenterally administering human anti-PD-1 antibody in which PD-L1 or PD-L2 is over-expressed postoperatively |
| 05/25/2006 | US20060110381 comprising a continuous, biocompatible liquid phase, a solid phase comprising porous or non-porous particles of a biocompatible polymer suitable for use in hemostasis and which are substantially insoluble in the liquid phase, and sterile thrombin |
| 05/25/2006 | US20060110380 Compositions for inhibiting thrombin-induced coagulation and methods of use |
| 05/25/2006 | US20060110379 Linkage of agents using microparticles |
| 05/25/2006 | US20060110378 Polypeptide belonging to a thioredoxin superfamily |
| 05/25/2006 | US20060110377 Immunologically privileged cells and uses thereof |
| 05/25/2006 | US20060110376 MDA-7 and free radicals in the treatment of cancer |
| 05/25/2006 | US20060110368 Medium for culturing autologous human progenitor stem cells and applications thereof |
| 05/25/2006 | US20060110363 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
| 05/25/2006 | US20060110362 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 05/25/2006 | US20060110358 Combination therapy for treatment of fibrotic disorders |
| 05/25/2006 | US20060110341 Cosmetic compositions containing Sophora alopecuroides L. extracts |
| 05/24/2006 | EP1659796A1 Method and system for providing a customized media list |
| 05/24/2006 | EP1659179A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659178A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659177A2 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 05/24/2006 | EP1659172A1 Adipogenic differentiation of human mesenchymal stem cells |
| 05/24/2006 | EP1659133A2 Human-murine chimeric antibodies against respiratory syncytial virus |
| 05/24/2006 | EP1659132A1 Biologically active bactericidal/permeability-increasing protein fragments |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |